Filter Results
:
(1,001)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
- 01 Jun 2017
- News
Turning Point: Addiction’s Impact
image by Jeffrey Decoster image by Jeffrey Decoster I was blindsided when my daughter told me, “I’m a heroin addict.” It was November 16, 2009, at a meeting with her drug counselor at Boston College. After I uttered a profanity and...
View Details
Keywords:
Melissa Weiksnar (MBA 1982)
- 06 Oct 2020
- Blog Post
2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)
Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white...
View Details
Ernest H. Volwiler
its pharmaceutical products. He contributed to the commercialization of penicillin and sulfa drugs during World War II and produced top level financial returns for Abbott during his tenure as CEO.
View Details
Keywords:
Healthcare
- 06 Dec 2021
- News
Vision: Sound Science
of scientific inquiry in gene-based hearing loss and inner-ear drug delivery: “In some infants with profound hearing impairment, there’s a mutation in one of those genes that results in loss of a protein that inner-ear cells need to...
View Details
Keywords:
Deb Blagg
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers association, Frazier has led the...
View Details
Keywords:
by Bill George
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had...
View Details
Keywords:
Linda Kush
- Web
Teams | New Venture Competition
in the eye. Lime Therapeutics Shardule Shah (MBA 2022) Prakrit Jena Dan Heller Harnessing its proprietary drug discovery platform to invent a new class of medicines for cancer. The Cyclist House Francisco Barroso (MBA 2022) Dmitri Hennion...
View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he...
View Details
Richard M. Furlaud
Furlaud focused on Squibb's pharmaceuticals, investing in research and development that ultimately led to the introduction of several new drugs. Furlaud's streamlining and consistent support of the company's cardiovascular drugs paid off...
View Details
Keywords:
Healthcare
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable biological View Details
- Portrait Project
Nicole Hanrahan
When I tell people I want to run an employment program for homeless drug addicts, many think I'm absolutely crazy. However, I want to devote my career to building just such a business. My pre-MBA experience of providing job training to...
View Details
- 02 Sep 2015
- News
Voting for Optimism in Baltimore
problem that includes reducing the drug trade and its effect on homicides in the city while, at the same time, improving processes within the police department. When people can’t expect the police to do certain things, it causes the...
View Details
- 01 Mar 2014
- News
Feedback
bulletin@hbs.edu. Write us a letter. This is your magazine. It needs your voice. Gene Williams, featured in the December 2013 HBS Alumni Bulletin Top Story The story of Gene Williams (MBA 1987) and his new drug development model hit a...
View Details
Keywords:
Health, Social Assistance
- 24 Jun 2016
- News
Reinventing Pharma
2004) began her career as a research scientist. Eventually expanding her responsibilities into business development led her to HBS, where she hoped to solidify her understanding of the intersection of science and business. Following graduation, she joined Novartis,...
View Details
- 01 Jun 2002
- News
Late Start, Dramatic Finish
the availability and cost of drugs used to treat HIV and AIDS in Africa. Fueled by doughnuts and an unsinkable team spirit, the HBS group worked for 24 hours straight to formulate the winning action plan. “We decided not only to design a...
View Details
- 23 Apr 2014
- HBS Case
Are Electronic Cigarettes a Public Good or Health Hazard?
Drug Administration is proposing the first federal oversight of the product. The very fact users could control the amount of nicotine they ingested led to worry that e-cigarettes would cause smokers to take in more nicotine, rather than...
View Details
- Student-Profile
A Jay Holmgren
of papers examining the efficacy of hospital IT systems at flagging and preventing adverse drug events. He credits the diverse expertise of his fellow doctoral students with helping him expand and enrich his research pursuits. “I’ve...
View Details
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance behavior in disease-carrying...
View Details
- 10 Nov 2020
- Sharpening Your Skills
Research News and Tips: Innovating Across Time Zones
Dany Bahar, Prithwiraj Choudhury, and Britta Glennon. Drugs approved in December are associated with more adverse effects New research reveals that drug approvals surge in the US in December, at month-ends,...
View Details
Keywords:
by Sean Silverthorne
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid...
View Details
Keywords:
by Wendy Guild